Want to see PACB full AI Analyst Report?
Remaining Performance Obligations
Represents contracted but unrecognized revenue from instrument orders, service agreements, and reagent commitments, giving visibility into near‑term booked revenue. Large RPOs suggest strong forward sales and revenue certainty; shrinking RPOs can warn of weakening demand or cancellations.RPO has trended down since late‑2024 with a pronounced drop in mid‑2025 and continued softness into Q1‑2026, reflecting weaker forward bookings and reduced near‑term revenue visibility—consistent with the lowered 2026 guide and softer instrument demand from promotions, APAC delays and delivery disruptions. Offsetting this, record consumables, improving Revio pull‑through and the SPRQ‑Nx commercial launch create a plausible path to rebuild backlog if adoption converts; however promotional ASPs, compute‑cost pressure and funding headwinds could keep RPO subdued.
Date | Remaining Performance Obligations |
|---|---|
Jun 30, 2026 | $47.90M |
Mar 31, 2026 | $46.60M |
Dec 31, 2025 | $49.20M |
Sep 30, 2025 | $48.70M |
Jun 30, 2025 | $56.60M |
Mar 31, 2025 | $58.70M |
Dec 31, 2024 | $58.60M |